35936627|t|Changing Spectrum of Acute Encephalitis Syndrome in India and a Syndromic Approach.
35936627|a|Acute encephalitis syndrome (AES) refers to an acute onset of fever and clinical neurological manifestation that includes mental confusion, disorientation, delirium, or coma, which may occur because of infectious or non-infectious causes. Cerebrospinal fluid (CSF) pleocytosis generally favors infectious etiology, and a normal CSF favors an encephalopathy or non-infectious AES. Among the infectious AES, viral, bacterial, rickettsial, fungal, and parasitic causes are the commonest. Geographical and seasonal clustering and other epidemiological characteristics are important in clinical decision making. Clinical markers like eschar, skin rash, myalgia, hepatosplenomegaly, thrombocytopenia, liver and kidney dysfunction, elevated serum CK, fronto-temporal or thalamic involvement on MRI, and anterior horn cell involvement are invaluable clues for the etiological diagnosis. Categorizing the AES cases into neurologic [Herpes simplex encephalitis (HSE), Japanese encephalitis (JE), and West Nile encephalitis (WNE)] and systemic (scrub typhus, malaria, dengue, and Chikungunya) helps in rational utilization of diagnostic and management resources. In neurological AES, cranial CT/MRI revealing frontotemporal lesion is consistent with HSE, and thalamic and basal ganglia lesions are consistent with JE. Cerebrospinal fluid nucleic acid detection test or IgM antibody for JE and HSE are confirmatory. Presence of frontotemporal involvement on MRI indicates acyclovir treatment pending virological confirmation. In systemic AES, CT/MRI, PCR for HSE and JE, and acyclovir therapy may not be useful, rather treatable etiologies such as malaria, scrub typhus, and leptospirosis should be looked for. If smear or antigen for malaria is positive, should receive antimalarial, if negative doxycycline and ceftriaxone should be started pending serological confirmation of scrub typhus, leptospira, or dengue. A syndromic approach of AES based on the prevalent infection in a geographical region may be developed, which may be cost-effective.
35936627	21	48	Acute Encephalitis Syndrome	Disease	MESH:D000071072
35936627	84	111	Acute encephalitis syndrome	Disease	MESH:D000071072
35936627	113	116	AES	Disease	MESH:D000071072
35936627	146	151	fever	Disease	MESH:D005334
35936627	224	238	disorientation	Disease	MESH:D003221
35936627	240	248	delirium	Disease	MESH:D003693
35936627	253	257	coma	Disease	MESH:D003128
35936627	286	296	infectious	Disease	MESH:D003141
35936627	304	314	infectious	Disease	MESH:D003141
35936627	323	342	Cerebrospinal fluid	Disease	MESH:D002559
35936627	344	348	CSF)	Disease	MESH:D002559
35936627	349	360	pleocytosis	Disease	MESH:D007964
35936627	378	388	infectious	Disease	MESH:D003141
35936627	412	415	CSF	Disease	MESH:D002559
35936627	426	440	encephalopathy	Disease	MESH:D001927
35936627	448	458	infectious	Disease	MESH:D003141
35936627	459	462	AES	Disease	MESH:D000071072
35936627	474	484	infectious	Disease	MESH:D003141
35936627	485	488	AES	Disease	MESH:D000071072
35936627	713	719	eschar	Disease	
35936627	721	730	skin rash	Disease	MESH:D005076
35936627	732	739	myalgia	Disease	MESH:D063806
35936627	741	759	hepatosplenomegaly	Disease	MESH:C535727
35936627	761	777	thrombocytopenia	Disease	MESH:D013921
35936627	779	807	liver and kidney dysfunction	Disease	MESH:D051437
35936627	824	826	CK	Gene	51727
35936627	980	983	AES	Disease	MESH:D000071072
35936627	1007	1034	Herpes simplex encephalitis	Disease	MESH:D020803
35936627	1036	1039	HSE	Disease	MESH:D020803
35936627	1042	1063	Japanese encephalitis	Disease	MESH:D004672
35936627	1065	1067	JE	Disease	MESH:D004672
35936627	1074	1096	West Nile encephalitis	Disease	MESH:D014901
35936627	1098	1101	WNE	Disease	MESH:D014901
35936627	1118	1130	scrub typhus	Disease	MESH:D012612
35936627	1132	1139	malaria	Disease	MESH:D008288
35936627	1141	1147	dengue	Disease	MESH:D003715
35936627	1153	1164	Chikungunya	Species	
35936627	1239	1255	neurological AES	Disease	MESH:D000071072
35936627	1282	1303	frontotemporal lesion	Disease	MESH:D057180
35936627	1323	1326	HSE	Disease	MESH:D020803
35936627	1332	1366	thalamic and basal ganglia lesions	Disease	MESH:D001480
35936627	1387	1389	JE	Disease	MESH:D004672
35936627	1391	1410	Cerebrospinal fluid	Disease	MESH:D002559
35936627	1459	1461	JE	Disease	MESH:D004672
35936627	1466	1469	HSE	Disease	MESH:D020803
35936627	1500	1526	frontotemporal involvement	Disease	MESH:D057180
35936627	1544	1553	acyclovir	Chemical	MESH:D000212
35936627	1610	1613	AES	Disease	MESH:D000071072
35936627	1631	1634	HSE	Disease	MESH:D020803
35936627	1639	1641	JE	Disease	MESH:D004672
35936627	1647	1656	acyclovir	Chemical	MESH:D000212
35936627	1720	1727	malaria	Disease	MESH:D008288
35936627	1729	1741	scrub typhus	Disease	MESH:D012612
35936627	1747	1760	leptospirosis	Disease	MESH:D007922
35936627	1807	1814	malaria	Disease	MESH:D008288
35936627	1869	1880	doxycycline	Chemical	MESH:D004318
35936627	1885	1896	ceftriaxone	Chemical	MESH:D002443
35936627	1951	1963	scrub typhus	Disease	MESH:D012612
35936627	1965	1975	leptospira	Species	171
35936627	1980	1986	dengue	Disease	MESH:D003715
35936627	2012	2015	AES	Disease	MESH:D000071072
35936627	2039	2048	infection	Disease	MESH:D007239
35936627	Negative_Correlation	MESH:D002443	MESH:D003715
35936627	Negative_Correlation	MESH:D004318	MESH:D003715
35936627	Negative_Correlation	MESH:D004318	MESH:D012612
35936627	Negative_Correlation	MESH:D002443	MESH:D012612

